XBIT Xbiotech Inc

XBiotech Inc is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases.

$15.97  -0.25 (-1.54%)
As of 06/18/2021 15:59:06 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  04/15/2015
Outstanding shares:  29,983,801
Average volume:  78,128
Market cap:   $486,337,252
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98400H102
ISIN:        CA98400H1029
Sedol:      BWD1LM2
Valuation   (See tab for details)
PE ratio:   -34.67
PB ratio:   1.36
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy